We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
175 result(s) found, displaying 81 to 90
-
Prescription medicine registrationActive ingredients: romiplostim.
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EVENITY romosozumab 105 mg/1.17mL injection solution syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KANJINTI trastuzumab 150 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KANJINTI trastuzumab 420 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KANJINTI trastuzumab 60 mg powder for injection vial.
-
-
Australian public assessment report (AusPar)AusPAR for Mvasi (bevacizumab) for treatment of various cancers